JAK2 and colorectal carcinoma: Other studies have confirmed that ATL-1 anticancer activity in CRC is associated with apoptosis induction and glycolysis suppression in CRC cells through inhibition of Janus kinase 2 (JAK2)/STAT3 signaling.